Oslo, 7 October 2025. With reference to today's webcast, please find enclosed the presentation, also made available at https://observemedical.com/. A recording of the presentation is also available at: Hegnar Media – Observe Medical Trading update 7 october 2025 (https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20251007_1) For further information, please contact: Jørgen Mann, CEO Observe Medical Mobile: +45 408 67 558 E-mail: jorgen.mann@observemedical.com Johan Fagerli, CFO…
Oslo, 25 September 2025 – Observe Medical ASA (the "Company" or "Observe Medical") announces further progress in the Italian market. The Company’s distributor in Italy has secured a public tender to supply UnoMeter™ products into the largest region in Italy, corresponding to an estimated olume of approximately 240,000 units annually for a period of three…
Oslo, 19 September 2025 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) will host a presentation with trading update Tuesday, 7 October 2025. Observe Medical invites investors, analysts, and other stakeholders to the presentation which will take place virtually Tuesday 7 October 2025, at 09:00 CET, and streamed via webcast at the…
Oslo, September 11, 2025 – Observe Medical ("the Company" or "Observe Medical") has initiated activities in 2 additional South American markets, Brazil and Colombia, representing a combined population of approximately 260 million. With this expansion, the Company’s UnoMeter™ branded product family is now represented in 43 countries worldwide. Jørgen Mann, CEO of Observe Medical, commented: "Our…
Oslo, August 21, 2025 – Observe Medical ("the Company" or "Observe Medical") has received additional orders from the distributor in Switzerland after several successful hospital conversions and also receives first orders from new distributor in Slovenia after hospital product evaluations. Jørgen Mann, CEO of Observe Medical, commented: " The Swiss market is a very critical market in…
Oslo, July 11, 2025 – Observe Medical (“the Company” or “Observe Medical”) is pleased to announce that it has received first orders for UnoMeter™ Safeti™ Plus from distributors covering Argentina and the seven Central American countries. This comes in addition to a previous order already received from Chile. These markets together represent approximately 75% of…
Oslo, June 24, 2025 – Observe Medical ("the Company" or "Observe Medical") is pleased to announce that UnoMeter[TM] Safeti[TM] Plus has been appointed exclusive winner of the tender in the largest region in Sweden, representing approximately 20% of the total Swedish market. In Finland UnoMeter[TM] Safeti[TM] has been awarded the tender for Helsinki and Tampere which…
Oslo, April 28, 2025 – Observe Medical ("the Company" or "Observe Medical") is happy to announce that UnoMeter[TM] Safeti[TM] Plus is now accepted by NHS to be included on the national listing for England. Also Observe Medical has received first order of UnoMeter[TM] Safeti[TM] Plus from Portugal and the journey to create a strategic partnership with Jiangsu…
With reference to today's webcast, please find enclosed the presentation, also made available at https://observemedical.com/. A recording of the presentation is also available at: https://sdk.companywebcast.com/sdk/player/?id=hegnarmedia_20250410_3&customBtnColor=da7038,674429 (https://eur03.safelinks.protection.outlook.com/?url=httpssdk.companywebcast.comsdkplayeridhegnarmedia_20250410_3customBtnColorda7038674429&data=0502johan.fagerliobservemedical.com95918ad22c144110968908dd66e57693139dbc03ecf246efb467a338c990a8d600638779858079459528UnknownTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ0&sdata=pG0x7hXETFnlsfcETvp0xYQ4Wlv1xEpVJkrVIwa0&reserved=0) For further information, please contact: Jørgen Mann, CEO Observe Medical Mobile: +45 408 67 558 E-mail: jorgen.mann@observemedical.com Johan Fagerli, CFO Observe Medical Mobile: +47 958 12 765 E-mail: johan.fagerli@observemedical.com About Observe Medical Observe Medical…
Oslo, 19 March 2025 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) will host an investor presentation with trading update Thursday, 10 April 2025, at 10:00 CET. Observe Medical invites investors, analysts, and other stakeholders to an investor presentation with trading update Thursday 10 April 2025, at 10:00 CET. The presentation will…
Oslo, 13 March, 2025 – Observe Medical ("the Company" or "Observe Medical") has received repeat orders and now first significant orders from the Nordic region where UnoMeter[™] Safeti[™] Plus historically has held a very dominating position. Historically, UnoMeter[™] Safeti[™] Plus has had a dominating market share in this region consistently exceeding 70% across most markets. The annual sales…
Oslo, 6 March, 2025 –Observe Medical ("the Company" or "Observe Medical") has received a significant repeat order from the very important Italian market that in 2021 represented almost 20 mNOK of the total UnoMeter™ annual sales. After testing UnoMeter™ Safeti™ Plus at key customers in the Italian market and subsequently received very positive feedback on…
Oslo, February 28, 2025 – Observe Medical ("the Company" or "Observe Medical") has received order from the very important UK market that in 2021 represented more than 40 mNOK of the total UnoMeter™ sales. The first significant deliveries of UnoMeter™ Safeti™ Plus to the distribution network started in January, with increasing levels in February, and the revenue…
Oslo, November 12[th], 2024 – Observe Medical ("the Company" or "Observe Medical") has today signed the DOC (Declaration of Conformity). This marks the final step for the establishment of a high-volume manufacturing platform for the UnoMeter™ product portfolio, consisting of UnoMeter™ 500 and UnoMeter™ Safeti™ Plus. The DOC is the final regulatory documentation that needs to be…
Oslo, August 22, 2024 – Observe Medical ("the Company" or "Observe Medical") has received its first order of UnoMeter 500 products from a distributor in South America. This initial order represents a significant step towards expanding our footprint in a region that holds historical importance for the UnoMeter product line. This marks a significant milestone as…
Oslo, August 19, 2024 -Observe Medical ("the Company" or "Observe Medical") will release its results for the first half year 2024 on Monday, 26 Augsut 2024. The presentation will be published on NewsWeb and theCompany's website at 07:00 CET on the same day. The Company will host a presentation and Q&Asession at 10:00 CET on…
Oslo, 25 June 2024 Reference is made to the announcement made by Observe Medical ASA (the "Company" or "Observe Medical", and, together with its subsidiaries, the "Group", OSE ticker "OBSRV") yesterday, on 24 June 2024, regarding the successfully placed private placement of new shares in the Company to raise gross proceeds of NOK 22 million…
Oslo, 4 June 2024 – Observe Medical ASA ("the Company" or "Observe Medical") announces that it has entered into a Letter of Intent (LOI) with Sulacare AS ("Sulacare") to collaborate on the commercial launch of Sulacare's innovative and proprietary female catheterization product. This partnership goes beyond leveraging Observe Medical’s established platform to commercialize and distribute…
Oslo, 3 June 2024 – Observe Medical ASA ("the Company" or "Observe Medical") continues to see positive momentum in the re-adoption of its UnoMeter™ brand of medical devices into NHS and across private hospitals in the United Kingdom and Ireland. Building on previous announcements, Observe Medical confirms that since the start of 2024, UnoMeter™…
Oslo, 31 May 2024 – Observe Medical ASA ("the Company" or "Observe Medical") announces that its subsidiary, Biim AS ("Biim"), has extended its agreement with Fresenius Medical Care ("Fresenius") for the supply of wireless pocketable ultrasound devices. The initial agreement with Fresenius was entered into in October 2021, with a one-year extension exercised in October…
